deltatrials
Completed INTERVENTIONAL NCT06030609

The Comparison Between Ringer Lactate Solution and Normal Saline With Dextrose Water in Post-Operative Period of Kidney Transplantation (RINNOR)

The Comparison Between Ringer Lactate Solution and Normal Saline With Dextrose Water in the First Week Post-Operative Period of Deceased Donor and Living Donor Kidney Transplantation

Sponsor: King Chulalongkorn Memorial Hospital

Updated 9 times since 2023 Last updated: Apr 16, 2026 Started: Sep 1, 2024 Primary completion: Dec 24, 2025 Completion: Mar 24, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Electrolyte Imbalance and Kidney Transplant; Complications and is currently completed. King Chulalongkorn Memorial Hospital leads this study, which shows 9 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Oct 2023 – ~Apr 2024 · 6 months · monthly snapshotNot Yet Recruiting~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshotNot Yet Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Feb 2025 · 3 months · monthly snapshotRecruiting~Feb 2025 – ~Jan 2026 · 11 months · monthly snapshotRecruiting~Jan 2026 – ~Feb 2026 · 31 days · monthly snapshot~Feb 2026 – ~Apr 2026 · 2 months · monthly snapshotApr 18, 2026 – present · 3 months · daily APICompleted

Change History

9 versions recorded
  1. Apr 18, 2026 — Present [daily]

    Completed

    Status: Active Not RecruitingCompleted · Phase: PHASE3None

  2. Feb 2026 — Apr 2026 [monthly]

    Active Not Recruiting PHASE3

    Status: CompletedActive Not Recruiting

  3. Jan 2026 — Feb 2026 [monthly]

    Completed PHASE3

    Status: RecruitingCompleted

  4. Feb 2025 — Jan 2026 [monthly]

    Recruiting PHASE3

  5. Nov 2024 — Feb 2025 [monthly]

    Recruiting PHASE3

    Status: Not Yet RecruitingRecruiting

Show 4 earlier versions
  1. Sep 2024 — Nov 2024 [monthly]

    Not Yet Recruiting PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Not Yet Recruiting PHASE3

  3. Apr 2024 — Jul 2024 [monthly]

    Not Yet Recruiting PHASE3

  4. Oct 2023 — Apr 2024 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

This is a randomized controlled pragmatic clinical trial. We aim to evaluate the effect of Ringer lactate solution (RLS) and normal saline solution (NSS) with dextrose water (D5W) on the electrolyte abnormality of kidney transplant recipients (KTR) during the first post-operative week. The problem with using NSS with or without D5W as a standard replacement fluid is the hyperchloremic metabolic acidosis which might compromise the kidney allograft function. A total 60 KTR will be enrolled and randomized to receive either RLS or NSS with D5W. The primary outcome is serum bicarbonate level at day 5 after transplantation. Secondary outcomes include the serum potassium, serum sodium, serum chloride, cytokine panel, and the incidence of delayed graft function.

Contact Information

Sponsor contact:
  • King Chulalongkorn Memorial Hospital
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations